Riskpilot← Back to searchSign inGet full accessUderm AB
ABActiveOrg 5590489737Källängstorget 10Retail sale of cosmetic and toilet articles · NACE 4775Est. 20166 employees
Revenue 2025
SEK 11,4M
+77% vs 2024
EBITDA margin
-16.5%
+50% vs 2024
Equity ratio
3.1%
Financial strength
Net profit 2025
SEK -1,9M
-88% vs 2024
| Revenue | SEK 11,4M | +77% |
| EBITDA | SEK -1,9M | +50% |
| Net profit | SEK -1,9M | -88% |
| Total assets | SEK 5,5M | +54% |
| Equity | SEK 169K | -85% |
| Employees | 6 | — |
Legal name
Uderm AB
Org number
5590489737
Legal form
Aktiebolag
NACE code
4775 · Retail sale of cosmetic and toilet articles
Founded
28 januari 2016
Share capital
SEK 50 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva konsultverksamhet inom hudvård, försäljning av hudvårdsprodukter och hudvårdsutrustning samt därmed förenlig verksamhet.
Address
Källängstorget 10
Phone
+46707328053
Email
info@uderm.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 5 264 | 5 484 | 6 120 | 8 486 | 8 357 | 6 336 | 6 449 | 11 424 |
| Staff expenses | — | — | — | — | — | — | — | — | −3 909 | — |
| EBITDA | 137 | 94 | 604 | 315 | 973 | 1 104 | 199 | −1 273 | −3 764 | −1 886 |
| Depreciation & amort. | −3 | −7 | −8 | −15 | −21 | −18 | −82 | −85 | −16 | −16 |
| EBIT | 134 | 87 | 596 | 300 | 952 | 1 086 | 117 | −1 358 | −3 780 | −1 902 |
| Net financials | — | — | — | — | −1 | −5 | −14 | −2 | 1 | −36 |
| Profit before tax | 134 | 87 | 448 | 200 | 701 | 1 081 | 103 | 33 | −1 029 | −1 938 |
| Tax | −33 | −23 | −115 | −67 | −162 | −242 | −35 | −24 | — | −0 |
| Net profit | 101 | 64 | 333 | 133 | 539 | 839 | 68 | 9 | −1 029 | −1 938 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 104 | 1 571 | 1 693 | 2 251 | 3 526 | 3 852 | 3 582 | 3 401 | 3 558 | 5 465 |
| Equity | 151 | 215 | 548 | 680 | 1 220 | 2 059 | 2 127 | 2 136 | 1 107 | 169 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 |
| Short-term debt | 953 | 1 356 | 997 | 1 323 | 1 808 | 1 295 | 957 | 1 265 | 2 451 | 5 296 |
| Total debt | 953 | 1 356 | 997 | 1 323 | 1 808 | 1 295 | 957 | 1 265 | 2 451 | 5 296 |
EBITDA margin
-16.5%
This company
15.8%
Market median
-204% vs market
20162025
Equity ratio
3.1%
This company
38.2%
Market median
-92% vs market
20162025
Return on equity
-1146.7%
This company
18.4%
Market median
-6332% vs market
20162025
Net profit margin
-17.0%
This company
8.1%
Market median
-310% vs market
20162025
Asset turnover
2.09×
This company
1.12×
Market median
+87% vs market
20162025
Debt / equity
31.34×
This company
0.62×
Market median
-4955% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-02-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KM Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
LM Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
TD Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Antero Medical AB | Company | 91.0% | 91.0% | 2026 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Antero Medical AB
Uderm AB Board members of Uderm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Margareta Frohm Nilsson | Chief Executive Officer | 0 companies |
| Lena Maria Liselotte Claesson | Chief Executive Officer | 0 companies |
| Tekin Deniz | Audit | 0 companies |
| Mats Anders Nilsson | Deputy Board Member | 0 companies |
| Fabian Amilcar Peralta | Deputy Board Member | 0 companies |